Yes. This compounded medication is dispensed by Strive Pharmacy pursuant to a valid prescription from a licensed provider following a telemedicine evaluation.

Common side effects include nausea, vomiting, diarrhea, constipation, and abdominal discomfort, particularly during the first few weeks as your body adjusts. These typically improve with continued use. Worsening of diabetic retinopathy has been reported — patients with a history of retinopathy should be monitored closely by their provider. Pancreatitis has been reported with this drug class — discontinue use and contact your provider immediately if you experience persistent, severe abdominal pain. In animal studies, GIP/GLP-1 receptor agonists have been associated with thyroid C-cell tumors; the relevance to humans is not established, but this medication is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or MEN 2.

Not for use in patients with a personal or family history of medullary thyroid carcinoma or MEN 2. Not recommended during pregnancy. Do not use alongside other GLP-1 or GIP receptor agonists.

Tirzepatide may slow gastric emptying and affect the absorption timing of other oral medications. Do not combine with other GLP-1 or GIP agonists. Disclose all medications to your provider.

Not recommended for patients with severe GI disease, active pancreatitis, or significant renal impairment. Patients with diabetic retinopathy should be monitored closely. Full provider review is required.